Jane Street
REVBU

Jane Street’s Revelation Biosciences, Inc. Unit REVBU Stock Holding History

Jane Street’s Portfolio REVBU Stock Details REVBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$540K – 9778
2020
Q4 		$540K Buy
+50,000
New +$508K ﹤0.01% 5613

Other funds holding REVBU

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's REVBU Position: Q1 2021 in Review

Jane Street sold out of Revelation Biosciences, Inc. Unit (REVBU) in Q1 2021, closing a stake of 50,000 shares — an estimated $540K sold.

Jane Street first reported a position in REVBU in Q4 2020 and held it in 1 quarter. The position peaked at $540K in Q4 2020. 4 funds tracked by Wall St. Rank hold REVBU as of Q1 2021.

  • Jane Street reported no remaining Revelation Biosciences, Inc. Unit position as of Q1 2021 after selling out during the quarter.
  • Jane Street sold 50,000 Revelation Biosciences, Inc. Unit shares in Q1 2021, an estimated $540K.
  • Jane Street first reported a position in Revelation Biosciences, Inc. Unit in Q4 2020 and held it in 1 quarter.
  • Jane Street's Revelation Biosciences, Inc. Unit position peaked at $540K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Revelation Biosciences, Inc. Unit as of Q1 2021.

Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.